In an op-ed published in the Capitol Hill newspaper, The Hill, HDA President and CEO John M. Gray noted that a commitment and robust effort from all supply chain stakeholders are necessary to help mitigate the nation’s opioid abuse epidemic. Mr. Gray also recognized the critical role of primary pharmaceutical distributors, who stand ready to be part of the solution.
“All of us in healthcare, without exception, play a role in addressing this epidemic,” said Gray. “Such a task cannot fall to one sector alone. We must marshal our collective resources, learn from the past, and look to the future to end the opioid epidemic.”
ABOUT THE HEALTHCARE DISTRIBUTION ALLIANCE
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.